Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Study of H. Pylori Putative Candidate Factors for Single- and Multi-Component Vaccine Development Publisher Pubmed



Mirzaei N1 ; Poursina F2 ; Moghim S2 ; Rashidi N3 ; Ghasemian Safaei H2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran
  2. 2. Department of Microbiology, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Laboratory Sciences, Ahvaz University of Medical Sciences, Ahvaz, Iran

Source: Critical Reviews in Microbiology Published:2017


Abstract

Helicobacter pylori has grown to colonize inside the stomach of nearly half of the world’s population, turning into the most prevalent infections in the universe. Medical care failures noticeably confirm the need for a vaccine to hinder or deal with H. pylori. This review is planned to discuss the most known factors as a vaccine candidate, including single (AhpC, BG, CagA, KatA, Fla, Hsp, HWC, Lpp, LPS, NAP, OMP, OMV, SOD, Tpx, Urease, VacA) and multi-component vaccines. Many promising results in the field of single and multivalent vaccine can be seen, but there is no satisfactory outcome and neither a prophylactic nor a therapeutic vaccine to treat or eradicate the infection in human has been acquired. Hence, selecting suitable antigen is an important factor as an appropriate adjuvant. Taken all together, the development of efficient anti-H. pylori vaccines relies on the fully understanding of the interactions between H. pylori and its host immune system. Therefore, more work should be done on epitope mapping, analysis of molecular structure, and determination of the antigen determinant region as well due to design a vaccine, preferably a multi-component vaccine to elicit specific CD4 T-cell responses that are required for H. pylori vaccine efficacy. © 2017 Informa UK Limited, trading as Taylor & Francis Group.
Experts (# of related papers)
Other Related Docs